K913505

Substantially Equivalent

ENZYGNOST TOXOPLASMOSIS/IGM

Applicant: Behring Diagnostics, Inc.
Product code: LGD
Advisory panel: Microbiology
Date received: 1991-08-07
Decision date: 1992-03-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Somerville, NJ, US

Adverse events under product code LGD

product code LGD

Malfunction: 502
Total: 502

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.